ARS Pharmaceuticals
SPRY
SPRY
70 hedge funds and large institutions have $94.7M invested in ARS Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 16 closing their positions.
Holders
70
Holders Change
-2
Holders Change %
-2.78%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
21
Reduced
28
Closed
16
Calls
$188K
Puts
$3K
Net Calls
+$185K
Net Calls Change
-$221K
Top Buyers
1 |
WA
1
Wasatch Advisors
Salt Lake City,
Utah
|
$10.4M |
2 |
2
Renaissance Technologies
New York
|
$2.35M |
3 |
PM
3
Prosight Management
Dallas,
Texas
|
$1.14M |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$926K |
5 |
5
Two Sigma Advisers
New York
|
$1.3M |